Neuralgia Treatment

Description

Global Neuralgia Treatment Market to Reach US$3.2 Billion by 2030

The global market for Neuralgia Treatment estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.2 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Surgery-based Treatment, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Drug-based Treatment segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$618.5 Million While China is Forecast to Grow at 9.6% CAGR

The Neuralgia Treatment market in the U.S. is estimated at US$618.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$660.1 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Neuralgia Treatment Market - Key Trends & Drivers Summarized

Why Is Neuralgia Treatment Becoming a Key Focus in Pain Management?

Neuralgia, a condition characterized by severe, sharp, and often chronic nerve pain, has become a major area of focus in pain management due to its debilitating impact on patients' quality of life. Neuralgia can result from nerve damage, infections, inflammation, or underlying conditions such as diabetes, multiple sclerosis, and postherpetic complications from shingles. Common types of neuralgia include trigeminal neuralgia, occipital neuralgia, and postherpetic neuralgia, each requiring tailored treatment approaches. Traditional pain relief methods such as nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids often provide limited relief, leading to increased demand for more effective treatments, including anticonvulsants, antidepressants, nerve blocks, and neuromodulation therapies. Advancements in neuralgia treatment now include minimally invasive surgical interventions such as microvascular decompression (MVD) and radiofrequency ablation (RFA), as well as emerging techniques like spinal cord stimulation (SCS) and targeted drug delivery systems. As the prevalence of chronic pain conditions rises globally, the neuralgia treatment market is witnessing increased investment in innovative pain management solutions that offer long-term relief and improved patient outcomes.

What Challenges Are Hindering Effective Neuralgia Treatment?

Despite advancements in pain management, several challenges continue to hinder the effective treatment of neuralgia. One of the primary concerns is the difficulty in accurately diagnosing neuralgia, as its symptoms can overlap with other neuropathic pain disorders, leading to misdiagnosis or delayed treatment. The complexity of nerve pain also means that treatment effectiveness varies significantly from patient to patient, requiring a trial-and-error approach that can prolong suffering. Additionally, many conventional neuralgia treatments, such as opioids, come with risks of dependency, addiction, and adverse side effects, necessitating the development of safer alternatives. High costs associated with advanced treatment options, including neuromodulation devices and surgical interventions, also limit accessibility, particularly in developing regions. Another major challenge is the lack of awareness and specialized pain management centers, leading to underdiagnosis and inadequate treatment for many patients. Furthermore, regulatory hurdles for novel pain management drugs and devices can delay market entry, restricting access to innovative neuralgia treatments. Addressing these challenges requires greater investment in research, enhanced medical training for healthcare providers, and improved access to affordable, evidence-based pain management therapies.

How Are Innovations Transforming Neuralgia Treatment?

The neuralgia treatment market is witnessing groundbreaking innovations aimed at improving pain relief, reducing side effects, and enhancing patient outcomes. One of the most promising advancements is the use of neuromodulation therapies, including transcutaneous electrical nerve stimulation (TENS), spinal cord stimulation (SCS), and dorsal root ganglion (DRG) stimulation, which modulate pain signals at the nerve level, providing long-term relief. Another major development is the emergence of targeted drug delivery systems that release pain medications directly at the affected nerve sites, reducing systemic side effects. Gene therapy and regenerative medicine are also gaining traction, with research exploring the potential of stem cell therapy and nerve growth factors to repair damaged nerves and restore normal function. Additionally, advancements in radiofrequency ablation (RFA) and cryoneurolysis are offering minimally invasive options for long-lasting pain relief by disrupting pain pathways without the need for extensive surgery. Artificial intelligence (AI) and machine learning are also being integrated into pain management, helping doctors personalize treatment plans based on patient-specific pain patterns and response data. As these innovations continue to evolve, the landscape of neuralgia treatment is shifting towards more effective, less invasive, and patient-centric solutions that offer lasting pain relief and improved quality of life.

What Is Driving the Growth of the Neuralgia Treatment Market?

The growth in the neuralgia treatment market is driven by several factors, including the rising prevalence of neuropathic pain disorders, increasing awareness of chronic pain management, and advancements in pain relief technologies. The aging global population, which is more prone to conditions such as shingles, diabetes-related nerve damage, and degenerative neurological diseases, is contributing to the rising incidence of neuralgia. Additionally, the growing emphasis on non-opioid pain management solutions is fueling the demand for alternative therapies, including neuromodulation, targeted drug delivery, and regenerative medicine. The expansion of pain management clinics and specialized healthcare facilities is also improving access to advanced neuralgia treatments, particularly in developed regions. Furthermore, increasing investments in research and development are accelerating the introduction of novel therapies, including biologics and AI-assisted treatment plans. Government initiatives promoting chronic pain management and reimbursement policies supporting innovative treatments are further boosting market growth. As neuralgia continues to be a significant public health concern, the demand for advanced, effective, and accessible treatment options is expected to rise, shaping the future of pain management and improving the lives of millions of affected individuals worldwide.

SCOPE OF STUDY:

The report analyzes the Neuralgia Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Surgery-based Treatment, Drug-based Treatment); End-Use (Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

Abbott Laboratories
Allergan plc
Astellas Pharma Inc.
AstraZeneca plc
Bayer AG
Biogen Inc.
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Daiichi Sankyo Company, Limited
Dr. Reddy's Laboratories
Eli Lilly and Company
Gilead Sciences, Inc.
GlaxoSmithKline plc (GSK)
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Product Code: MCP32322

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Neuralgia Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Prevalence of Neuropathic Disorders Propels Demand for Neuralgia Treatment Solutions
- Increasing Geriatric Population Base Strengthens Business Case for Long-Term Neuralgia Management
- Growing Awareness Around Chronic Pain Conditions Drives Adoption of Early Intervention Therapies
- Technological Advancements in Nerve Stimulation Devices Expand Addressable Market Opportunity
- Emergence of Minimally Invasive Procedures Spurs Growth in Interventional Pain Management
- Integration of AI and Predictive Analytics in Pain Diagnosis Enhances Precision and Supports Market Expansion
- Increasing Availability of Targeted Drug Delivery Systems Drives Demand for Personalized Treatment
- Shift Towards Multimodal Pain Therapy Approaches Drives Adoption of Complementary Treatments
- Expansion of Telemedicine and Remote Care Solutions Accelerates Access to Neuralgia Treatment
- Rising Investment in Pain Research and Innovation Pipelines Fuels Development of Next-Gen Therapeutics
- Favorable Reimbursement Policies in Developed Economies Sustain Growth Momentum Across Key Markets
- Escalating Use of Cannabinoid-Based Therapies Throws the Spotlight on Alternative Pain Management Modalities
- Strong Pipeline of Biologics and Monoclonal Antibodies Expands Future Treatment Horizons
- Increasing Regulatory Scrutiny on Opioid Usage Creates Opportunities for Safer Treatment Alternatives
- Growing Collaboration Between Pharma and MedTech Players Spurs Innovation in Neurostimulation Technologies
- Expansion of Pain Clinics and Specialty Care Centers Enhances Market Penetration in Emerging Regions
- Rising Incidence of Diabetic Neuropathy and Post-Herpetic Neuralgia Drives Chronic Pain Treatment Demand
- Increased Focus on Patient-Centric Care Models Strengthens Business Case for Home-Based Therapies
- Regulatory Push for Non-Addictive Pain Therapies Drives Innovation in Drug Development Pipelines
- Growth in Wearable and Implantable Pain Modulation Devices Drives Demand for Tech-Enabled Solutions
- Adoption of Real-World Evidence (RWE) in Clinical Decision Making Enhances Market Credibility and Adoption
- Government-Led Public Health Initiatives and Funding Support Expand Market Access in Underserved Regions
- Surge in Mental Health Comorbidities with Chronic Pain Disorders Spurs Holistic Treatment Approaches
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Neuralgia Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Neuralgia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Neuralgia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Neuralgia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Surgery-based Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Surgery-based Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Surgery-based Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Drug-based Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Drug-based Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Drug-based Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Hospital & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 20: USA Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: USA 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 23: USA Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 24: USA Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: USA 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
- TABLE 26: Canada Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: Canada 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 29: Canada Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 30: Canada Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: Canada 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 32: Japan Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: Japan 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 35: Japan Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 36: Japan Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: Japan 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 38: China Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: China Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: China 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 41: China Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: China Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: China 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 44: Europe Recent Past, Current & Future Analysis for Neuralgia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Neuralgia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: Europe 15-Year Perspective for Neuralgia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: Europe 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 50: Europe Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Europe Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Europe 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 53: France Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: France Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: France 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 56: France Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: France Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: France 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 59: Germany Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Germany 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 62: Germany Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Germany Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: Germany 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
- TABLE 65: Italy Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Italy 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 68: Italy Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: Italy Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Italy 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 71: UK Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: UK 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 74: UK Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: UK Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: UK 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
- TABLE 77: Spain Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Spain Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: Spain 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 80: Spain Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Spain Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Spain 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 83: Russia Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Russia Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Russia 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 86: Russia Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Russia Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Russia 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Rest of Europe Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Rest of Europe 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: Rest of Europe Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: Rest of Europe 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Neuralgia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 96: Asia-Pacific Historic Review for Neuralgia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 97: Asia-Pacific 15-Year Perspective for Neuralgia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Asia-Pacific Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 100: Asia-Pacific 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Asia-Pacific Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 103: Asia-Pacific 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 104: Australia Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Australia Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 106: Australia 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 107: Australia Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Australia Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 109: Australia 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
INDIA
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 110: India Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: India Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 112: India 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 113: India Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: India Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 115: India 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 116: South Korea Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: South Korea Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 118: South Korea 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 119: South Korea Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: South Korea Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 121: South Korea 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: Rest of Asia-Pacific Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Rest of Asia-Pacific Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
LATIN AMERICA
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 128: Latin America Recent Past, Current & Future Analysis for Neuralgia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 129: Latin America Historic Review for Neuralgia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 130: Latin America 15-Year Perspective for Neuralgia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 131: Latin America Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Latin America Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 133: Latin America 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 134: Latin America Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Latin America Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 136: Latin America 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 137: Argentina Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Argentina Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 139: Argentina 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 140: Argentina Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Argentina Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 142: Argentina 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 143: Brazil Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Brazil Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 145: Brazil 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 146: Brazil Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Brazil Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 148: Brazil 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MEXICO
- TABLE 149: Mexico Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: Mexico Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 151: Mexico 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 152: Mexico Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 153: Mexico Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 154: Mexico 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Rest of Latin America Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 157: Rest of Latin America 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: Rest of Latin America Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 160: Rest of Latin America 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MIDDLE EAST
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 161: Middle East Recent Past, Current & Future Analysis for Neuralgia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 162: Middle East Historic Review for Neuralgia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 163: Middle East 15-Year Perspective for Neuralgia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 164: Middle East Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Middle East Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 166: Middle East 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 167: Middle East Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Middle East Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 169: Middle East 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
IRAN
- TABLE 170: Iran Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: Iran Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 172: Iran 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 173: Iran Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: Iran Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 175: Iran 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ISRAEL
- TABLE 176: Israel Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: Israel Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 178: Israel 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 179: Israel Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: Israel Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 181: Israel 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SAUDI ARABIA
- TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: Saudi Arabia Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 184: Saudi Arabia 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: Saudi Arabia Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 187: Saudi Arabia 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 188: UAE Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: UAE Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 190: UAE 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 191: UAE Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: UAE Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 193: UAE 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Middle East Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 196: Rest of Middle East 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Middle East Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 199: Rest of Middle East 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AFRICA
- Neuralgia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 200: Africa Recent Past, Current & Future Analysis for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 201: Africa Historic Review for Neuralgia Treatment by Treatment Type - Surgery-based Treatment and Drug-based Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 202: Africa 15-Year Perspective for Neuralgia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery-based Treatment and Drug-based Treatment for the Years 2015, 2025 & 2030
- TABLE 203: Africa Recent Past, Current & Future Analysis for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Africa Historic Review for Neuralgia Treatment by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 205: Africa 15-Year Perspective for Neuralgia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030